A multimodal nanoparticle for preoperative magnetic resonance imaging and intraoperative optical brain tumor delineation.
暂无分享,去创建一个
Ralph Weissleder | Umar Mahmood | Lee Josephson | R. Weissleder | L. Josephson | M. Kircher | U. Mahmood | Raymond S King | Moritz F Kircher
[1] Michael Schulder,et al. Intraoperative magnetic resonance imaging: impact on brain tumor surgery. , 2003, Cancer control : journal of the Moffitt Cancer Center.
[2] Vasilis Ntziachristos,et al. Shedding light onto live molecular targets , 2003, Nature Medicine.
[3] Ralph Weissleder,et al. Feasibility of in vivo multichannel optical imaging of gene expression: experimental study in mice. , 2002, Radiology.
[4] Ralph Weissleder,et al. Magnetic Nanosensors for the Detection of Oligonucleotide Sequences. , 2001, Angewandte Chemie.
[5] Anita Mahadevan-Jansen,et al. In Vivo Brain Tumor Demarcation Using Optical Spectroscopy¶ , 2001, Photochemistry and photobiology.
[6] M. Knauth,et al. Low-field interventional MRI in neurosurgery: finding the right dose of contrast medium , 2001, Neuroradiology.
[7] C Zimmer,et al. Magnetic labeling of activated microglia in experimental gliomas. , 2001, Neoplasia.
[8] C R Wirtz,et al. Monocrystalline iron oxide nanoparticles: possible solution to the problem of surgically induced intracranial contrast enhancement in intraoperative MR imaging. , 2001, AJNR. American journal of neuroradiology.
[9] C Zimmer,et al. Pharmacokinetic analysis of glioma compartments with dynamic Gd-DTPA-enhanced magnetic resonance imaging. , 2000, Magnetic resonance imaging.
[10] V. Ntziachristos,et al. Concurrent MRI and diffuse optical tomography of breast after indocyanine green enhancement. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[11] C R Wirtz,et al. Surgically induced intracranial contrast enhancement: potential source of diagnostic error in intraoperative MR imaging. , 1999, AJNR. American journal of neuroradiology.
[12] R Weissleder,et al. High-efficiency intracellular magnetic labeling with novel superparamagnetic-Tat peptide conjugates. , 1999, Bioconjugate chemistry.
[13] R Weissleder,et al. Improved delineation of human brain tumors on MR images using a long‐circulating, superparamagnetic iron oxide agent , 1999, Journal of magnetic resonance imaging : JMRI.
[14] R Weissleder,et al. Novel gliosarcoma cell line expressing green fluorescent protein: A model for quantitative assessment of angiogenesis. , 1998, Microvascular research.
[15] H Stepp,et al. Intraoperative detection of malignant gliomas by 5-aminolevulinic acid-induced porphyrin fluorescence. , 1998, Neurosurgery.
[16] L. Josephson,et al. Use of AMI-227 as an oral MR contrast agent. , 1994, Magnetic resonance imaging.
[17] R Weissleder,et al. Monocrystalline iron oxide nanocompounds (MION): Physicochemical properties , 1993, Magnetic resonance in medicine.
[18] R Weissleder,et al. Superparamagnetic iron oxide: pharmacokinetics and toxicity. , 1989, AJR. American journal of roentgenology.
[19] V Blazek,et al. Optical properties of human brain tissue, meninges, and brain tumors in the spectral range of 200 to 900 nm. , 1987, Neurosurgery.
[20] J. Thiessen,et al. Indocyanine green pharmacokinetics in the rabbit. , 1984, Canadian journal of physiology and pharmacology.